(55) demonstrated that long-term exposure of MDA-MB-231 breast cancer cells to relaxin resulted in reduced tumor growth and decreased cell motility and invasiveness, likely mediated through downregulation of S100A4 expression, despite the known MMP-inducing effects of relaxin. The gene discussed is S100A4; the disease is breast cancer.